GREAT POINT PARTNERS LLC Quant / Systematic

Location: Greenwich, CT

CIK: 0001281446 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value: $349M (100.0% shares, 0.0% debt)

Holdings (39)

ADAMAS PHARMACEUTICALS INC 9.1%
Value $31.93M Shares 2,109,099 Est. Cost $18.75 Unrealized
VNDA VANDA PHARMACEUTICALS INC 8.7%
Value $30.28M Shares 2,705,758 Est. Cost $10.50 Unrealized -7.7%
SYNERGY PHARMACEUTICALS DEL 8.3%
Value $28.84M Shares 7,590,000 Est. Cost $4.49 Unrealized
EXEL EXELIXIS INC 7.2%
Value $24.99M Shares 3,200,000 Est. Cost $4.88 Unrealized +18.1%
DERMIRA INC 6.7%
Value $23.4M Shares 800,000 Est. Cost $29.25 Unrealized
BLUEBIRD BIO INC 6.2%
Value $21.64M Shares 500,000 Est. Cost $42.67 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 6.1%
Value $21.36M Shares 470,000 Est. Cost $41.64 Unrealized +10.6%
EGRX EAGLE PHARMACEUTICALS INC 6.1%
Value $21.27M Shares 548,290 Est. Cost $41.64 Unrealized 0.0%
ZOGENIX INC 5.6%
Value $19.65M Shares 2,440,959 Est. Cost $11.56 Unrealized
IGNYTA INC 5.0%
Value $17.55M Shares 3,238,703 Est. Cost $5.54 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 3.4%
Value $11.86M Shares 538,024 Est. Cost $26.18 Unrealized 0.0%
SAGE THERAPEUTICS INC 2.8%
Value $9.943M Shares 330,000 Est. Cost $30.13 Unrealized
TETRAPHASE PHARMACEUTICALS I 2.8%
Value $9.888M Shares 2,299,529 Est. Cost $6.71 Unrealized
CONNECTURE INC 2.7%
Value $9.328M Shares 4,127,232 Est. Cost $9.01 Unrealized
XNCR XENCOR INC 2.4%
Value $8.546M Shares 450,000 Est. Cost $11.83 Unrealized +15.9%
AUPH AURINIA PHARMACEUTICALS INC 2.1%
Value $7.192M Shares 2,457,144 Est. Cost $3.52 Unrealized -22.5%
ALCOBRA LTD 1.8%
Value $6.351M Shares 1,414,573 Est. Cost $5.99 Unrealized
RAPTOR PHARMACEUTICAL CORP 1.5%
Value $5.254M Shares 978,350 Est. Cost $5.98 Unrealized
SRPT SAREPTA THERAPEUTICS INC 1.3%
Value $4.556M Shares 238,900 Est. Cost Unrealized
SUNESIS PHARMACEUTICALS INC 1.3%
Value $4.477M Shares 8,173,937 Est. Cost $1.47 Unrealized
BOVIE MEDICAL CORP 1.3%
Value $4.395M Shares 2,680,000 Est. Cost $2.72 Unrealized
ARADIGM CORP 1.3%
Value $4.383M Shares 1,002,962 Est. Cost $8.85 Unrealized
INTRA CELLULAR THERAPIES INC 1.1%
Value $3.882M Shares 100,000 Est. Cost $38.82 Unrealized
OCERA THERAPEUTICS INC 1.1%
Value $3.731M Shares 1,963,777 Est. Cost $6.20 Unrealized
SERES THERAPEUTICS INC 1.0%
Value $3.486M Shares 120,000 Est. Cost Unrealized
TENAX THERAPEUTICS INC 0.8%
Value $2.838M Shares 1,108,593 Est. Cost $3.93 Unrealized
FOAMIX PHARMACEUTICALS LTD 0.5%
Value $1.745M Shares 274,756 Est. Cost $6.35 Unrealized
ADVERUM BIOTECHNOLOGIES INC 0.5%
Value $1.738M Shares 550,116 Est. Cost $3.16 Unrealized
ASND ASCENDIS PHARMA A S 0.3%
Value $1.015M Shares 76,511 Est. Cost $13.27 Unrealized
CALADRIUS BIOSCIENCES INC 0.3%
Value $900K Shares 1,525,244 Est. Cost $1.87 Unrealized
DIPEXIUM PHARMACEUTICALS INC 0.2%
Value $871K Shares 87,914 Est. Cost $9.91 Unrealized
VCEL VERICEL CORP 0.2%
Value $570K Shares 253,502 Est. Cost $2.85 Unrealized +1.3%
PARATEK PHARMACEUTICALS INC 0.1%
Value $407K Shares 29,266 Est. Cost $25.19 Unrealized
AXOVANT SCIENCES LTD 0.1%
Value $321K Shares 25,000 Est. Cost $12.84 Unrealized
REVANCE THERAPEUTICS INC 0.1%
Value $295K Shares 21,665 Est. Cost $13.62 Unrealized
STREAMLINE HEALTH SOLUTIONS 0.1%
Value $182K Shares 151,611 Est. Cost $6.45 Unrealized
RIGEL PHARMACEUTICALS INC 0.0%
Value $112K Shares 50,000 Est. Cost $2.08 Unrealized
ARDX ARDELYX INC 0.0%
Value $30,000 Shares 3,444 Est. Cost $8.17 Unrealized 0.0%
AMARIN CORP PLC 0.0%
Value $4,000 Shares 2,000 Est. Cost $2.00 Unrealized